000			01383 a2200301 4500
005			20250516231306.0
264		0	_c20151204
008			201512s 0 0 eng d
022			_a1542-7714
024	7		_a10.1016/j.cgh.2014.08.025 _2doi
040			_aNLM _beng _cNLM
100	1		_aDeepak, Parakkal
245	0	0	_aRisk of Myeloid Neoplasms in Inflammatory Bowel Disease Patients Is Linked to Exposure to Thiopurines and Not With Tumor Necrosis Factor-alpha Inhibitors. _h[electronic resource]
260			_bClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association _cOct 2015
300			_a1857-8 p. _bdigital
500			_aPublication Type: Letter; Comment
650	0	4	_aAzathioprine _xadverse effects
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadverse effects
650	0	4	_aInflammatory Bowel Diseases _xdrug therapy
650	0	4	_aLeukemia, Myeloid, Acute _xepidemiology
650	0	4	_aMale
650	0	4	_aMyelodysplastic Syndromes _xepidemiology
700	1		_aStobaugh, Derrick J
773	0		_tClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association _gvol. 13 _gno. 10 _gp. 1857-8
856	4	0	_uhttps://doi.org/10.1016/j.cgh.2014.08.025 _zAvailable from publisher's website
999			_c24132033 _d24132033